ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 992,87
0,18%
Dow Jones
38 686,32
1,51%
DAX
18 497,94
-0,09%
Brent Oil
81,295
0,00%
Bitcoin
67 761,21
0,05%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Vitae Pharmaceuticals, Inc. (MM) (VTAE)

  7. Vitae Pharmaceuticals, Inc. (MM) (VTAE) Actualités

VTAE

VITAE PHARMACEUTICALS, INC (VTAE)

Vitae Pharmaceuticals, Inc. (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:VTAE
DateHeureSourceTitreSymboleSociété
15/02/201700h15Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
04/11/201621h03Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
31/10/201611h01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
25/10/201622h44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
25/10/201622h12Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
25/10/201622h05Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
25/10/201622h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
25/10/201614h53Edgar (US Regulatory)(25-NSE)NASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
25/10/201613h57Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
25/10/201613h56Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
26/09/201622h50Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
26/09/201622h37Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
23/09/201622h31PR Newswire (US)VITAE SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Vitae Pharmaceuticals, Inc. (VTAE) Over the Pro...NASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
21/09/201622h44Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
15/09/201621h01Business WireINVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Vitae Pharmaceuticals, Inc. And Encourages ...NASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
15/09/201616h43Business WireSHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Regarding the Fairness of the Sale of Vitae Pharmaceutica...NASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
15/09/201602h15Business WireSHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Vitae Pharmaceuticals, Inc. And Encourag...NASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
14/09/201623h21PR Newswire (US)Harwood Feffer LLP Announces Investigation of Vitae Pharmaceuticals, Inc.NASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
14/09/201623h09Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
14/09/201617h09Business WireVITAE PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of BuyoutNASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
14/09/201615h40Dow Jones NewsAllergan to Buy Vitae Pharmaceuticals for $639 MillionNASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
14/09/201614h00PR Newswire (US)Allergan to Acquire Vitae Pharmaceuticals Adding Innovative Development Programs for Dermatologic ConditionsNASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
01/09/201622h05GlobeNewswire Inc.Vitae Pharmaceuticals to Present at Wells Fargo Healthcare ConferenceNASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
15/08/201622h31Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
12/08/201622h32Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
11/08/201613h30GlobeNewswire Inc.Vitae Pharmaceuticals to Present at Wedbush PacGrow Healthcare ConferenceNASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
10/08/201622h05GlobeNewswire Inc.Vitae Pharmaceuticals Appoints Scott Applebaum as General Counsel and Corporate SecretaryNASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
04/08/201622h11Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
03/08/201622h05GlobeNewswire Inc.Vitae Pharmaceuticals Reports Second Quarter 2016 Operating and Financial ResultsNASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
01/08/201623h30GlobeNewswire Inc.Vitae Pharmaceuticals to Announce Second Quarter 2016 Financial Results on August 3, 2016NASDAQ:VTAEVitae Pharmaceuticals, Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:VTAE

Dernières Valeurs Consultées

BIT
P1Z2D2
NLBNPIT1Z2D2 20991231 19...
TG
A284X4
Ferrovial Emisiones
BIT
P1YEQ9
NLBNPIT1YEQ9 20240920 380
ASX
MOH
Moho Resources NL
TG
A38J3W
Reconstruction Credit In...
COIN
TFBXUST
Truefeedback
USOTC
MEDD
Medical Imaging (CE)
TG
A3KNZZ
Arval Service Lease
EU
FR2CIBFS3692
Credit Agricole CIB FCIA...
TG
ZAL
Zalando
TG
A2RYE5
Republic of Cyprus
BIT
P1ZRT2
NLBNPIT1ZRT2 20351221 84...
BITMOT
2661138
Efsf Fx 3.5% Apr29 Eur
NASDAQI
HSV
Settle ISE Australian Do...
ASX
ECS
ECS Botanics
COIN
GGENUSD
GemeGen
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés